NCT00688415 2019-09-25Safety and Pharmacologic Study of VTX-2337 in Patients With Advanced CancerCelgenePhase 1 Completed33 enrolled
NCT01289210 2019-09-25VTX-2337 in Combination With Radiotherapy in Patients Low-Grade B-cell LymphomasCelgenePhase 1/2 Terminated2 enrolled 4 charts